169 related articles for article (PubMed ID: 30268432)
21. PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.
Mowla S; Pinnock R; Leaner VD; Goding CR; Prince S
Biochem J; 2011 Jan; 433(1):145-53. PubMed ID: 20942798
[TBL] [Abstract][Full Text] [Related]
22. TBX3 and its splice variant TBX3 + exon 2a are functionally similar.
Hoogaars WM; Barnett P; Rodriguez M; Clout DE; Moorman AF; Goding CR; Christoffels VM
Pigment Cell Melanoma Res; 2008 Jun; 21(3):379-87. PubMed ID: 18444963
[TBL] [Abstract][Full Text] [Related]
23. Basal transcription of the human TBX3 gene, a key developmental regulator which is overexpressed in several cancers, requires functional NF-Y and Sp1 sites.
Smith J; Mowla S; Prince S
Gene; 2011 Oct; 486(1-2):41-6. PubMed ID: 21784138
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-137 represses Klf4 and Tbx3 during differentiation of mouse embryonic stem cells.
Jiang K; Ren C; Nair VD
Stem Cell Res; 2013 Nov; 11(3):1299-313. PubMed ID: 24084696
[TBL] [Abstract][Full Text] [Related]
25. JNK Signaling in Stem Cell Self-Renewal and Differentiation.
Semba T; Sammons R; Wang X; Xie X; Dalby KN; Ueno NT
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283767
[TBL] [Abstract][Full Text] [Related]
26. TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines.
Fan W; Huang X; Chen C; Gray J; Huang T
Cancer Res; 2004 Aug; 64(15):5132-9. PubMed ID: 15289316
[TBL] [Abstract][Full Text] [Related]
27. Short communication: Expression of T-box 2 and 3 in the bovine mammary gland.
Hoffman ML; McFadden KK; Hoagland TA; Kazmer GW; Govoni KE
J Dairy Sci; 2014 Jul; 97(7):4322-8. PubMed ID: 24767885
[TBL] [Abstract][Full Text] [Related]
28. Human breast progenitor cell numbers are regulated by WNT and TBX3.
Arendt LM; St Laurent J; Wronski A; Caballero S; Lyle SR; Naber SP; Kuperwasser C
PLoS One; 2014; 9(10):e111442. PubMed ID: 25350852
[TBL] [Abstract][Full Text] [Related]
29. Establishment of the TBX-code reveals aberrantly activated T-box gene TBX3 in Hodgkin lymphoma.
Nagel S; Meyer C
PLoS One; 2021; 16(11):e0259674. PubMed ID: 34807923
[TBL] [Abstract][Full Text] [Related]
30. TBX2 and TBX3: the special value for anticancer drug targets.
Lu J; Li XP; Dong Q; Kung HF; He ML
Biochim Biophys Acta; 2010 Dec; 1806(2):268-74. PubMed ID: 20624445
[TBL] [Abstract][Full Text] [Related]
31. TBX3 Directs Cell-Fate Decision toward Mesendoderm.
Weidgang CE; Russell R; Tata PR; Kühl SJ; Illing A; Müller M; Lin Q; Brunner C; Boeckers TM; Bauer K; Kartikasari AE; Guo Y; Radenz M; Bernemann C; Weiß M; Seufferlein T; Zenke M; Iacovino M; Kyba M; Schöler HR; Kühl M; Liebau S; Kleger A
Stem Cell Reports; 2013; 1(3):248-65. PubMed ID: 24319661
[TBL] [Abstract][Full Text] [Related]
32. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
[TBL] [Abstract][Full Text] [Related]
33. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome.
Carlson H; Ota S; Campbell CE; Hurlin PJ
Hum Mol Genet; 2001 Oct; 10(21):2403-13. PubMed ID: 11689487
[TBL] [Abstract][Full Text] [Related]
34. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
35. Leukemia inhibitory factor regulates marmoset induced pluripotent stem cell proliferation via a PI3K/Akt‑dependent Tbx‑3 activation pathway.
Ke M; He Q; Hong D; Li O; Zhu M; Ou WB; He Y; Wu Y
Int J Mol Med; 2018 Jul; 42(1):131-140. PubMed ID: 29620145
[TBL] [Abstract][Full Text] [Related]
36. Expression of TBX3 in Hepatocellular Carcinoma and Its Clinical Implication.
Li Z; Wang Y; Duan S; Shi Y; Li S; Zhang X; Ren J
Med Sci Monit; 2018 Dec; 24():9324-9333. PubMed ID: 30578408
[TBL] [Abstract][Full Text] [Related]
37. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.
Fillmore CM; Gupta PB; Rudnick JA; Caballero S; Keller PJ; Lander ES; Kuperwasser C
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21737-42. PubMed ID: 21098263
[TBL] [Abstract][Full Text] [Related]
38. An integrated computational approach to screening of alkaloids inhibitors of TBX3 in breast cancer cell lines.
Paul A; Limon MBH; Hossain MM; Raza MT
J Biomol Struct Dyn; 2023 Apr; 41(7):3025-3041. PubMed ID: 35253621
[TBL] [Abstract][Full Text] [Related]
39. Loss of TBX3 enhances pancreatic progenitor generation from human pluripotent stem cells.
Mukherjee S; French DL; Gadue P
Stem Cell Reports; 2021 Nov; 16(11):2617-2627. PubMed ID: 34653400
[TBL] [Abstract][Full Text] [Related]
40. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.
Carlson H; Ota S; Song Y; Chen Y; Hurlin PJ
Oncogene; 2002 May; 21(24):3827-35. PubMed ID: 12032820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
